Advertisement
Screener

Protalix BioTherapeutics, Inc. (PLX) Graph

PLX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $19.90M; Cost of revenue $7.76M; Research and development $4.35M; Selling, general and administrative $3.11M.
  • 2026-03-31: Revenue $33.75M; Cost of revenue $4.13M; Research and development $5.43M; Selling, general and administrative $3.05M.
  • 2025-12-31: Revenue $9.12M*; Cost of revenue $4.62M*; Research and development $5.63M*; Selling, general and administrative $3.53M*.
  • 2025-09-30: Revenue $17.85M; Cost of revenue $8.32M; Research and development $4.47M; Selling, general and administrative $2.93M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PLX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.License And Service$68.00KProduct$19.83MRevenue$19.90MCost of revenue$7.76MOperating income$4.67MResearch & development$4.35MSelling, general& administrative$3.11MPre-tax income$4.86MIncome tax$1.08MNet income$3.78M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PLX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Single OperatingSegment$19.90MRevenue$19.90MCost of revenue$7.76MOperating income$4.67MResearch & development$4.35MSelling, general& administrative$3.11MPre-tax income$4.86MIncome tax$1.08MNet income$3.78M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$19.90M$7.76M$4.35M$3.11M$1.08M$3.78M
2026-03-31$33.75M$4.13M$5.43M$3.05M$2.82M$18.32M
2025-12-31$9.12M*$4.62M*$5.63M*$3.53M*$728.00K*-$5.50M*
2025-09-30$17.85M$8.32M$4.47M$2.93M-$116.00K$2.35M
2025-06-30$15.66M$5.87M$5.99M$2.62M$497.00K$164.00K
2025-03-31$10.11M$8.18M$3.48M$2.60M-$113.00K-$3.62M
2024-09-30$17.96M$8.38M$3.00M$2.60M$607.00K$3.24M
2024-06-30$13.47M$9.46M$2.96M$3.48M-$69.00K-$2.20M
2024-03-31$3.75M$2.60M$2.89M$3.12M-$138.00K-$4.59M
2023-09-30$10.35M$4.89M$3.67M$3.67M$133.00K-$1.85M
2023-06-30$35.08M$6.15M$4.47M$4.03M$308.00K$19.34M
2023-03-31$9.59M$3.08M$5.85M$3.12M$195.00K-$3.13M
2022-09-30$14.18M$7.07M$7.39M$2.85M(m)-$3.57M
2022-06-30$8.75M$4.09M$7.58M$2.61M(m)-$5.33M
2022-03-31$16.09M$6.03M$8.77M$3.15M(m)-$2.29M
2021-09-30$12.05M$3.70M$7.28M$2.95M(m)-$4.20M
2021-06-30$6.43M$4.73M$7.69M$3.17M(m)-$11.24M
2021-03-31$11.32M$4.76M$7.12M$3.14M(m)-$5.47M
2020-09-30$10.79M$2.87M$7.69M$2.82M(m)-$4.44M
2020-06-30$10.97M$1.83M$9.19M$2.19M(m)-$4.15M
2020-03-31$21.65M$3.43M$10.34M$3.19M(m)$1.67M
2019-12-31(m)(m)(m)(m)(m)$291.00K
2019-09-30$14.25M$3.21M$10.00M$2.59M(m)-$3.56M
2019-06-30$12.25M$2.69M$13.32M$2.07M(m)-$7.74M
2019-03-31$10.44M$2.04M$11.70M$2.23M(m)-$7.26M
2018-12-31(m)(m)(m)(m)(m)-$5.43M
2018-09-30$663.00K$1.92M$10.07M$4.09M(m)-$5.32M
2018-06-30$2.01M$2.18M$7.48M$2.16M(m)-$8.46M
2018-03-31$4.55M$2.92M$7.29M$2.50M(m)-$7.24M
2017-09-30$7.53M$6.07M$7.12M$2.84M(m)-$11.44M
2017-06-30$6.36M$5.52M$9.30M$2.81M(m)$450.00K
2017-03-31$2.89M$2.09M$5.97M$2.54M(m)-$59.15M
2016-09-30$4.67M$4.25M$6.35M$2.01M(m)-$7.29M
2016-06-30$1.77M$1.68M$10.01M$2.21M(m)-$10.85M
2016-03-31$679.00K$523.00K$7.33M$2.00M(m)-$8.60M
2015-09-30$1.34M$223.00K$5.07M$2.16M(m)-$3.82M
2015-06-30$1.34M$225.00K$6.02M$2.00M(m)-$5.07M
2015-03-31$1.69M$282.00K$6.10M$1.82M(m)-$5.97M
2014-09-30$2.40M$1.80M$8.05M$2.01M(m)-$8.01M
2014-06-30$2.42M$1.60M$7.08M$1.57M(m)-$6.12M
2014-03-31$6.70M$4.07M$8.15M$3.71M(m)-$7.34M
2013-09-30$2.28M$1.59M$7.72M$1.78M(m)-$5.75M
2013-06-30$2.26M$1.32M$7.99M$2.18M(m)-$6.84M
2013-03-31$3.57M$971.00K$7.75M$2.10M(m)-$4.32M
2012-09-30$3.72M$2.37M$8.33M(m)(m)-$5.48M
2012-06-30$26.11M$3.28M$10.54M(m)(m)$9.64M
2012-03-31$3.86M$1.32M$8.85M(m)(m)-$5.90M
2011-09-30$1.13M$220.00K$9.34M(m)(m)-$8.88M
2011-06-30$764.00K$132.00K$8.77M(m)(m)-$13.69M
2011-03-31$4.13M$778.00K$10.56M(m)(m)-$5.05M
2010-09-30$3.18M(m)$6.32M(m)(m)-$2.47M
2010-06-30$1.14M$0.00$10.35M(m)(m)-$10.04M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2026-06-30$53.65M$11.89M$9.78M$6.16M$3.91M$22.09M
2025-06-30$25.77M$14.05M$9.47M$5.23M$384.00K-$3.46M
2024-06-30$17.22M$12.06M$5.85M$6.60M-$207.00K-$6.80M
2023-06-30$44.66M$9.23M$10.32M$7.15M$503.00K$16.21M
2022-06-30$24.84M$10.12M$16.35M$5.76M(m)-$7.62M
2021-06-30$17.75M$9.50M$14.81M$6.31M(m)-$16.72M
2020-06-30$32.61M$5.25M$19.53M$5.38M(m)-$2.48M
2019-06-30$22.69M$4.74M$25.02M$4.30M(m)-$15.01M
2018-06-30$6.56M$5.11M$14.76M$4.66M(m)-$15.70M
2017-06-30$9.25M$7.61M$15.27M$5.35M(m)-$58.70M
2016-06-30$2.45M$2.20M$17.35M$4.20M(m)-$19.45M
2015-06-30$3.03M$507.00K$12.12M$3.82M(m)-$11.04M
2014-06-30$9.12M$5.68M$15.23M$5.28M(m)-$13.46M
2013-06-30$5.83M$2.29M$15.74M$4.29M(m)-$11.16M
2012-06-30$29.97M$4.60M$19.39M(m)(m)$3.74M
2011-06-30$4.89M$910.00K$19.33M(m)(m)-$18.74M
2010-06-30$2.28M$0.00$19.32M(m)(m)-$18.00M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-09-30$43.62M$22.37M$13.93M$8.16M$268.00K-$1.10M
2024-09-30$35.18M$20.43M$8.85M$9.19M$400.00K-$3.56M
2023-09-30$55.01M$14.13M$13.99M$10.82M$636.00K$14.36M
2022-09-30$39.02M$17.20M$23.73M$8.61M(m)-$11.19M
2021-09-30$29.80M$13.20M$22.09M$9.26M(m)-$20.91M
2020-09-30$43.40M$8.12M$27.21M$8.20M(m)-$6.92M
2019-09-30$36.93M$7.95M$35.02M$6.88M(m)-$18.57M
2018-09-30$7.22M$7.02M$23.75M$8.74M(m)-$21.02M
2017-09-30$16.77M$13.68M$22.39M$8.19M(m)-$70.14M
2016-09-30$7.12M$6.45M$23.70M$6.21M(m)-$26.74M
2015-09-30$4.36M$730.00K$17.19M$5.99M(m)-$14.86M
2014-09-30$11.52M$7.48M$23.28M$7.29M(m)-$21.47M
2013-09-30$8.12M$3.88M$23.47M$6.07M(m)-$16.91M
2012-09-30$33.70M$6.97M$27.72M(m)(m)-$1.74M
2011-09-30$6.02M$1.13M$28.67M(m)(m)-$27.62M
2010-09-30$5.47M(m)$25.65M(m)(m)-$20.47M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeIncome taxNet income
2025-12-31$52.74M$26.99M$19.57M$11.68M$996.00K-$6.60M
2024-12-31$53.40M$24.32M$12.97M$12.19M$1.22M$2.93M
2023-12-31$65.49M$22.98M$17.09M$14.96M$254.00K$8.31M
2022-12-31$47.64M$19.59M$29.35M$11.71M$530.00K-$14.93M
2021-12-31$38.35M$16.35M$29.73M$12.73M(m)-$27.58M
2020-12-31$62.90M$10.87M$38.17M$11.15M(m)-$6.52M
2019-12-31$54.69M$10.89M$44.62M$9.90M(m)-$18.28M
2018-12-31$34.24M$9.30M$33.33M$10.92M(m)-$26.46M
2017-12-31$21.08M$15.23M$32.17M$11.53M(m)-$83.44M
2016-12-31$9.20M$8.40M$30.41M$9.36M(m)-$29.36M
2015-12-31$4.36M$730.00K$24.89M$7.28M(m)$58.04M
2014-12-31$3.52M$630.00K$27.35M$9.23M(m)-$29.94M
2013-12-31$0.00$0.00$29.23M$8.05M(m)-$27.79M
2012-12-31$34.87M$8.14M$36.66M$9.76M(m)-$11.62M
2011-12-31$8.39M$1.52M$37.82M(m)(m)-$36.53M
2010-12-31$6.64M$4.38M$37.69M(m)(m)-$29.00M
2009-12-31$388.00K$3.58M$27.39M(m)(m)-$31.44M

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95